Jonathan McNeill insider trades

Open-market stock purchases and sales by Jonathan McNeill, President and COO at Crescent Biopharma, Inc, from SEC Form 4 filings since Sep 16, 2020.

Recent trades

DateStockTradeValue
Sep 18, 2026CBIO Crescent Biopharma, IncSold$64.1K
Sep 16, 2026CBIO Crescent Biopharma, IncSold$13.1K
Jun 22, 2026CBIO Crescent Biopharma, IncSold$370K
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 15, 2025CBIO Crescent Biopharma, IncBought (not open market)—
Dec 8, 2025CBIO Crescent Biopharma, IncBought (not open market)—

Companies traded

  • CBIO Crescent Biopharma, Inc: 3 sales, last Sep 18, 2026
  • DYN Dyne Therapeutics, Inc: 34 sales, last Aug 19, 2024

Get free alerts when Jonathan McNeill files a new trade →